Hillhurst Biopharmaceuticals, Inc.

Liberating patients from the burden of sickle cell disease

MONTROSE, United States · Founded 2015 · $2.0M raised

Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$2.0M
Last Round
$2.0M GrantMay 2025
Rounds
4

About

Hillhurst Biopharmaceuticals is a clinical-stage biopharmaceutical company developing novel oral therapies for sickle cell disease and related conditions. Its proprietary GLASS platform enables oral delivery of therapeutic agents that are safer and more convenient for at-home administration. The company's lead candidate HBI-002 targets sickle cell disease and Parkinson's disease, with a follow-on non-opioid compound targeting acute pain.

Summary

Hillhurst Biopharmaceuticals, Inc. is a Biotech company based in MONTROSE, United States, founded in 2015. It has raised $2.0M in total across 4 rounds, most recently a $2.0M Grant round in May 2025. Investors include National Institutes of Health and Michael J. Fox Foundation.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantMay 2025

Sign up to see all 4 rounds

Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hillhurst Biopharmaceuticals, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/hillhurst-biopharmaceuticals-inc"><img src="https://indexed.vc/api/badge/company/hillhurst-biopharmaceuticals-inc" alt="Hillhurst Biopharmaceuticals, Inc. on Indexed.vc" width="260" height="76" /></a>